Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
February 03, 2022
As of October 5, 2021, 15 African countries ratified the African Medicines Agency (AMA) treaty, entering into force the second specialized health agency of the African Union. The treaty struggled to get sufficient support for more than a decade after AMA was conceptualized at the 60th World Health O...
Blog Post
January 31, 2022
The Omicron variant has rapidly become the dominant variant of COVID-19, with many low- and middle- income countries (LMICs) observing a rapid increase in cases. In this blog we argue that protecting healthcare workers, and health systems in general, is now an even higher priority. We prop...
Blog Post
January 12, 2022
In November, we co-hosted an online event with USAID MTaPS and heard from experts in LMIC national regulatory authorities, donor agencies, and academia on supporting regulators and streamlining registration processes to improve the availability of quality assured medicines around the world. In this ...
Blog Post
December 20, 2021
High-income countries play a key role in the global response to Omicron. Their decisions can help increase global vaccination coverage, curb the spread of current variants, and prevent the emergence of new ones. Here we outline three actions high-income countries should take to help end the pandemic...
Blog Post
December 20, 2021
CGD co-hosted an online event in November with the U4 Anti-Corruption Resource Centre to discuss the progress and challenges in pursuit of a transparent and equitable roll out of COVID-19 vaccine. Following on earlier calls for transparency, this event built on new research from U4 and pointed ...
Blog Post
December 13, 2021
In the language of economists, opportunity cost refers to the return or other forms of benefit that we could have received, but gave up, to take another course of action. In mathematical terms, it is the difference between the utility of what we have chosen and that from the foregone choice. Or, in ...
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...